MassMutual Private Wealth & Trust’s Fulgent Genetics FLGT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-142
Closed -$2.82K 2406
2025
Q2
$2.82K Sell
142
-127
-47% -$2.48K ﹤0.01% 1845
2025
Q1
$4.55K Sell
269
-307
-53% -$5.23K ﹤0.01% 1641
2024
Q4
$10.6K Buy
576
+172
+43% +$3.36K ﹤0.01% 1238
2024
Q3
$8.78K Sell
404
-41
-9% -$917 ﹤0.01% 1169
2024
Q2
$8.73K Buy
445
+394
+773% +$8.22K ﹤0.01% 1139
2024
Q1
$1.11K Buy
+51
New +$1.27K ﹤0.01% 1676
2023
Q2
Sell
-58
Closed -$1.81K 1945
2023
Q1
$1.81K Buy
+58
New +$1.87K ﹤0.01% 1447
2022
Q3
Sell
-21
Closed -$1K 1678
2022
Q2
$1K Sell
21
-279
-93% -$15.3K ﹤0.01% 1308
2022
Q1
$19K Buy
300
+25
+9% +$1.65K ﹤0.01% 595
2021
Q4
$28K Buy
275
+13
+5% +$1.14K ﹤0.01% 558
2021
Q3
$24K Sell
262
-10
-4% -$909 ﹤0.01% 567
2021
Q2
$25K Hold
272
﹤0.01% 547
2021
Q1
$26K Buy
+272
New +$28.1K ﹤0.01% 494

Other funds holding FLGT

MassMutual Private Wealth & Trust's FLGT Position: Q3 2025 in Review

MassMutual Private Wealth & Trust sold out of Fulgent Genetics (FLGT) in Q3 2025, closing a stake of 142 shares — an estimated $2.82K sold.

MassMutual Private Wealth & Trust first reported a position in FLGT in Q1 2021 and held it in 13 quarters. The position peaked at $28K in Q4 2021. 163 funds tracked by Wall St. Rank hold FLGT as of Q3 2025.

  • MassMutual Private Wealth & Trust reported no remaining Fulgent Genetics position as of Q3 2025 after selling out during the quarter.
  • MassMutual Private Wealth & Trust sold 142 Fulgent Genetics shares in Q3 2025, an estimated $2.82K.
  • MassMutual Private Wealth & Trust first reported a position in Fulgent Genetics in Q1 2021 and held it in 13 quarters.
  • MassMutual Private Wealth & Trust's Fulgent Genetics position peaked at $28K in Q4 2021.
  • 163 funds tracked by Wall St. Rank held Fulgent Genetics as of Q3 2025.

Based on MassMutual Private Wealth & Trust's 13F filing for Q3 2025, filed 22 Oct 2025.